Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Turns Eye to Healthcare; Lee Hood, Come on Down

SAN FRANCISCO, Jan. 7 - Paradigm Genetics has put its stake in healthcare, the company said at an international healthcare conference here on Monday.

"We've been thought of as an ag company up to now," said John Ryals, the firm's CEO. "This is a real transition for us. We're showing our healthcare side."

Speaking at the 20th annual JPMorgan H&Q Healthcare Conference, Ryals said Paradigm Genetics was working to commercialize mass spec equipment and bioinformatics technology being developed with Thermo Finnigan and Lion Bioscience, respectively.

The mass spec equipment built by Thermo Finnigan with Paradigm modifications would allow "mass specs to talk to each other," said Ryals, allowing several samples to run over a number of different types of mass specs. Ryals said the technology might be ready for market in the next year.

The informatics platform it plans to market with Lion in the next 18 months includes a dictionary of the human metabolome, which Ryals estimated would eventually include 2,000 to 3,000 small molecules, and data visualization tools. Paradigm, based in Research Triangle, NC, currently uses the tools for internal R&D.

"We haven't been talking about this technology. We didn't want to invite a lot of competition in this area," said Ryals.

Why the coming out party now?

"It's all part of the plan we had four years ago to move towards healthcare," he said. "We developed ag first. We're not going to abandon it, we're just adding to it."

Ryals sees the company emerging as a "fully integrated drug-discovery effort" with agriculture as one division.

In another nod to its newly announced R&D focus on human health, the company on Monday announced a new member of their board: Lee Hood, director of the Institute for Systems Biology. Hood represents the first medical doctor on the board, according to a company spokesperson.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.